Perbedaan DCI Indonesia Tbk dan Merck Tbk.: DCI Indonesia Tbk diperdagangkan di Rp206.000 (kapitalisasi pasar 491,05 T, volume 24 jam 700), sedangkan Merck Tbk. diperdagangkan di Rp3.890 (kapitalisasi pasar 1,75 T, volume 24 jam 29,1 rb). Perbedaan utamanya: DCI Indonesia Tbk jauh lebih besar — sekitar 280,6× kapitalisasi pasar Merck Tbk., dan Merck Tbk. lebih aktif diperdagangkan (29,1 rb vs 700). Mana yang lebih baik tergantung tujuan investasimu.
| DCII | MERK | |
|---|---|---|
Kapitalisasi Pasar | 491,05 T | 1,75 T |
Volume | 700 | 29,1 rb |
Lot | 7 | 291 |
Perputaran | 144,2 jt | 113,37 jt |
Harga Rata-rata | 206.000 | 3.895,98 |
Nilai Transaksi | 144,2 jt | 113,37 jt |
Harga Ekuilibrium Indikatif | — | 3.890 |
Volume Ekuilibrium Indikatif | — | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT DCI Indonesia Tbk (the Company) was established in Indonesia based on Notarial Deed No. 143 of Buntario Tigris, S.H., S.E., M.H., on July 18, 2011. The Company started its commercial operations in 2013. The Company parent entity and ultimate controlling party is DCI International Holding Pte. Ltd., Singapore.
Selengkapnya di halaman DCII →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →